and 2015. Prescription claims were examined for statin, ACEi/ARB, and AP medications. Linear regression analysis was performed to assess for trends.
Objectives: Vascular pathology, including arterial rupture, critical limb ischemia, phlegmasia, and mesenteric ischemia require urgent or emergent evaluation and intervention. Definitive treatment often requires transfer to tertiary care facilities. Studies looking at interhospital transfer for ruptured aneurysm have concluded that there is a need for a more systematic and streamlined systems for transferring these timesensitive patients but have yet to examine all vascular emergencies. This study aimed to review a single tertiary care center's 5-year experience with the development and implementation of a Level One Vascular Emergency (L1VE) Program, designed to decrease barriers to transfer and expedite definitive care for all urgent and emergent vascular pathologies.
Methods: The L1VE Program, an integrated transfer system with a single access to facilitate physician-to-physician communication, transfer of patients and imaging, as well as activation of resources, was developed for all vascular emergencies. Original transfer and treatment algorithms for the L1VE program were examined and compared to current practice. Retrospective review of all patients transferred between the L1VE program's inception in 2012 through the end of 2016 was conducted. Transfers were reviewed by level of acuity as well as indications for transfer and operative procedures. The five most prevalent pathologies were tracked and analyzed for compounded annual growth rate (CAGR) and percent of total transfers.
Results: A total of 619 cases met inclusion criteria between 2012 and 2016. Transfer occurred from 56 medical centers. The most common reason for transfer in descending order were aortic pathology, acute and critical limb ischemia, carotid disease, graft infection, mesenteric ischemia, and venous disease (Table I ). Over the study period, the overall number of aggregate transfers grew from 76 to 125 per year for a compounded annual growth rate over the 4-year period of 13.2%. Acute aortic syndrome saw the greatest CAGR at 31.6%, followed by critical Objectives: As care of vascular emergencies becomes more regionalized, the cost of providing emergency care to patients with ruptured aneurysms rests largely on tertiary medical centers. These lifesaving procedures may place excessive fiscal strain on an already overtaxed system. The objective of this study was to define and quantify the cost of repairing ruptured aneurysms and compare treatment modalities.
Methods: From 2013 to 2015, 82 ruptured abdominal and thoracic aortic aneurysms were treated operatively at our 734-bed tertiary referral center. For each case, total hospital payments, overall cost, and hospital margin were calculated. Direct variable costs were itemized and included operating room costs, anesthesia, operating room supplies/implants, imaging, medications, emergency department costs, and room and board. Case-mix index and length of stay were recorded and benchmarked against other large ($500 bed) academic medical centers using risk-adjusted University Health System Consortium data.
Results: The 82 ruptured aortic aneurysms treated over the 2-year period included 55 abdominal aneurysms (rAAA) and 27 thoracic aneurysms (rTAA). Of the rAAA patients, 41 were treated with endovascular repair (EVAR) and 12 underwent open repair. The mean overall cost of EVAR was $39,341, with a hospital margin of $1462 for the admission. The mean overall cost of open repair was $49,280, with a hospital margin of $5465 for the admission. The highest direct variable costs for EVAR were implants (48%) and room/board (32%); the highest for open was room/board including intensive care unit (45%). Case-mix indices were comparable (4.1 for EVAR vs 4.5 for open repair). Mean length of stay was 9.2 days in the EVAR group and 16.7 days in the open repair group. There overall length of stay for rAAA was similar between our institution and other large academic medical centers (10.9 vs 10.6 days).
Conclusions: Emergency ruptured aneurysm repair at a tertiary care center is an expensive endeavor with a narrow margin. Despite increased length of stay and higher overall costs, hospital reimbursement was substantially better for open rAAA repair (profit margin 11.1% vs 3.6% for EVAR). Without reform of reimbursement for emergent procedures, repair of ruptured aneurysms may be difficult to sustain in the era of cost containment.
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PC136. Objectives: This study was conducted to (1) demonstrate a novel mathematical method to determine an optimal treatment policy for abdominal aortic aneurysms (AAAs) and (2) propose a potential gender-specific treatment policy for patients with AAAs.
Methods: We recently proposed a mathematical framework to produce an optimal treatment policy using so-called Markov decision processes (MDPs). This policy takes into account factors that are ignored by the current clinical policy (eg, the life-expectancy and the agedependent surgical mortality). The resulting policy is optimal with respect to the number of quality-adjusted life-years that the patient is expected to accumulate until death. This framework is then used to model the treatment policies for men and women with varying operative mortalities. The resulting policies are illustrated in a figure and qualitatively compared.
Results: The Fig shows the optimal treatment policy for men, which is structurally different from current clinical guidelines (surgery at 55 mm). Instead, the threshold is age dependent; that is, our model predicts that younger patients may benefit from surgery at smaller diameters. When comparing men and women, it is evident that with equal operative mortality our model supports the notion that women should be operated earlier than men. However, our results indicate that this recommendation heavily relies on the operative mortality.
Conclusions: Here we present a potentially useful method to construct treatment policies for patients with AAAs. We provide mathematically rigorous support for the clinical guidelines which state that women should be operated at smaller diameters than men but also point to the limitations in a fixed threshold. The model presented here may in the future serve as a base that can be extended with patient-specific co-morbidities and other factors that should influence treatment policy. In conclusion, this abstract supports the notion that no single threshold is optimal for all patients.
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